Optimizing tumor-associated antigen-stimulated autologous dendritic cell and cytokine-induced killer cell coculture to enhance cytotoxicity for cancer immunotherapy in manufacturing

BACKGROUND: Dendritic Cell Cytokine-induced killer cell (DC-CIK) coculture treatment in cancer immunotherapy has been shown to be effective. However, the cost of DC- CIK therapy is prohibitive for many patients, and the lack of standard manufacturing processes and treatment strategies are major limi...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Yi-Yen, Luo, Shao-Ciao, Lee, Chung-Hsin, Tang, Chien-Lun, Shen, Chiung-Chyi, Cheng, Wen-Yu, Yang, Yi-Chin, Yang, Meng-Yin, Yen, Chun-Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10311787/
https://www.ncbi.nlm.nih.gov/pubmed/37386444
http://dx.doi.org/10.1186/s12865-023-00552-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10311787/
https://www.ncbi.nlm.nih.gov/pubmed/37386444
http://dx.doi.org/10.1186/s12865-023-00552-5

Ejemplares similares